Argenx
This company develops immunology solutions by leveraging an antibody innovation ecosystem where scientists and engineers collaborate. They focus on engineering first-in-class product candidates designed to modulate IgG antibodies for treating severe autoimmune diseases. Their pipeline includes antibody therapies targeting FcRn and C2 pathways for conditions like generalized myasthenia gravis and CIDP.
Traction –/10
HQ unknown
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- This company develops immunology solutions by leveraging an antibody innovation ecosystem where scientists and engineers collaborate. They focus on engineering first-in-class product candidates designed to modulate IgG antibodies for treating severe autoimmune diseases. Their pipeline includes antibody therapies targeting FcRn and C2 pathways for conditions like generalized myasthenia gravis and CIDP.